Drug giant Pfizer Inc. Monday announced its agreement to acquire Anacor Pharmaceuticals, Inc., the developer of atopic dermatitis drug crisaborole, for $99.25 per Anacor share, in cash. The total transaction value, net of cash, is approximately $5.2 billion. In pre-market activity on Nasdaq, Anacor shares were gaining around 54 percent.